Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis

Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis

(2009) J. W. Choi et al.   CARCINOGENESIS

AIMP2 promotes TNF -dependent apoptosis via ubiquitin-mediated degradation of TRAF2

(2009) J. W. Choi et al.   JOURNAL OF CELL SCIENCE

Alternative Splicing in Lung Cancer

(2009) Ruben Pio et al.   Journal of Thoracic Oncology

Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis

(2009) Mi Jeong Kwon et al.   PLoS One

Determination of Three-dimensional Structure and Residues of the Novel Tumor Suppressor AIMP3/p18 Required for the Interaction with ATM

(2008) Kyung-Jin Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biodegradable poly(ester amine) based on glycerol dimethacrylate and polyethylenimine as a gene carrier

(2008) Rohidas B. Arote et al.   JOURNAL OF GENE MEDICINE

The splicing-factor oncoprotein SF2/ASF activates mTORC1

(2008) R. Karni et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aminoacyl tRNA synthetases and their connections to disease

(2008) S. G. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53

(2008) J. M. Han et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA